BehrouzSalehianMD

Adrenal Disease, Diabetes, Pituitary Disorders & Neuroendocrinology, Thyroid

Associate Professor, City of Hope and Beckman Research Institute

Dr. Salehian is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1500 Duarte Rd
Duarte, CA 91010
Phone+1 626-359-8111

Fax+1 626-218-5310

Charles R Drew University of Medicine and Science, College of MedicineResidency, Internal Medicine, 1995 - 1997
Kirk Kerkorian School of Medicine at UNLVResidency, Internal Medicine, 1994 - 1995
Los Angeles County-Harbor-UCLA Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1993 - 1994
Tehran University of Medical Sciences School of MedicineClass of 1979

MEASuRE: Metreleptin Effectiveness And Safety Registry Start of enrollment: 2016 Jan 15
Recruiting
Roles: Contact, Principal Investigator

PubMed

Worse survival and higher rates of relapse in U.S. Armenians with papillary thyroid cancer.
Karen Tsai, Katerina Arca, Philip H G Ituarte, Thomas Gernon, Behrouz Salehian
Laryngoscope Investigative Otolaryngology. 2024-12-01
Only a Train Can Mask Another Train.
Behrouz Salehian, Melvin Yan
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale. 2023-03-29
9 citations
First-In-Human Pilot PET Immunoimaging Study ofCu-Anti-Carcinoembryonic Antigen Monoclonal Antibody (hT84.66-M5A) in Patients with Carcinoembryonic Antigen-Producing C...
Jeffrey Y C Wong, David M Yamauchi, Vikram Adhikarla, Jennifer Simpson, Paul H Frankel
Cancer Biotherapy & Radiopharmaceuticals. 2023-02-01